Learning Objectives:
- Understand how the changing definition of preeclampsia affects diagnosis and management
- Understand how angiogenic biomarkers help to improve prediction of preeclampsia and its adverse outcomes
- Understand how future management, with the help of digital tools, might further improve clinical decision making
Session date:
02/24/2023 - 8:00am to 9:00am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Stefan Verlohren, MD, PhD